NCT06782607View on ClinicalTrials.gov

Clinical Impact of a Multiplex Rapid Diagnostic Pneumonia Panel Testing in Critically-ill Patients with Severe Hospital-acquired Pneumonia, Ventilator-associated Pneumonia and Community-acquired Pneumonia with High Risk of Multidrug Resistant Pathogen

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

October 1, 2027

Conditions
Infectious Disease of LungMolecular DiagnosisPneumonia
Interventions
DIAGNOSTIC_TEST

Pneumonia Panel by FilmArray

The Pneumonia Panel comprehensively identifies 33 potential pathogen targets from sputum-like (including endotracheal aspirate) and bronchoalveolar lavage (BAL)-like (including mini-BAL) samples. For 15 of the bacteria, the Pneumonia Panel provides semi-quantitative results, which may help determine whether an organism is a colonizer or a pathogen.

Trial Locations (1)

10700

Siriraj Hospital, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT06782607 - Clinical Impact of a Multiplex Rapid Diagnostic Pneumonia Panel Testing in Critically-ill Patients with Severe Hospital-acquired Pneumonia, Ventilator-associated Pneumonia and Community-acquired Pneumonia with High Risk of Multidrug Resistant Pathogen | Biotech Hunter | Biotech Hunter